Our Portfolio

  • BE

    Be is purpose-built to allow companies to streamline legal and operational workflows. Be lets businesses easily automate, monitor, and schedule key outcomes for their internal and external stakeholders.

  • NORACHEM

    Norachem uses AI-based generative design to make novel drugs for specific diseases - from scratch. Using generative design to tailor molecules for specific diseases, their algorithms can access a region of near-infinite chemical space while simultaneously optimizing for ease of synthesis, low toxicity, and high binding affinity— resulting in faster, less expensive, and superior drug molecules.

  • PREAMBLE

    Preamble is the next-gen performance and preventative medicine for those that want to live longer, healthier lives. Their mission is to catch health problems before they catch us. Focused on cutting-edge technology and grounded in personalization, Preamble is here to radically change health outcomes.

  • SOSV

    SOSV is a global venture capital firm that offers multi-stage investment starting in our deeply resourced, deep tech startup programs, IndieBio and HAX, with locations in New York City, Newark and San Francisco.

  • VERSUS

    Versus is the result of technology, legal and product experience converging. Versus has created a novel security architecture that enables its users to safely leverage AI for document sharing, collaboration and full case management from intake through conclusion of a legal matter.